California

For veterinary prescriptions that may not be refilled between May 1, and June 30, 2021 (due to the one-year time limitation on prescriptions), the director of the Department of Consumer Affairs extends an order waiving the California Code of Regulations, title 16, section 2032.1, subdivision (c) to the extent it prohibits a veterinarian from prescribing a drug for a duration longer than one year from the date the veterinarian examined the animal and prescribed the drug, subject to the condition that any such prescription may be refilled for a total period not to exceed 18 months from the date the veterinarian last examined the animal and prescribed the drug.

Also in California, recent Medi-Cal Rx News updates include the following:
• The Pharmacy Provider Self-Attestation Process has been extended through May 9, 2021, and has a new web address. If your company already submitted your self-attestation and received a confirmation email from CODSurvey@mercer.com, please disregard April 30, 2021, notice.
Changes to the Contract Drugs List have been made effective May 1, 2021.
Changes to the Contract Drugs List – Authorized Drug Manufacturer Labeler Codes have also been made effective May 1.

Lastly in California, the Medi-Cal Update Bulletin 990 – April 2021 includes the following items of interest. See bulletin for additional information.
• A new DUR Educational Article titled “Drug Safety Communication: Potential Increased Arrhythmia Risk from Lamotrigine (PDF)” is available on the DUR: Educational Articles page of the Medi-Cal website.
• Updates to the List of Enteral Nutrition Products effective for dates of service on or after March 1 have been made available.
• The MAPC per Unit of Measure for HCPCS code A4657 in The Medical Supplies Billing Codes, Units, and Quantity Limits spreadsheet has been corrected to ‘By Report”.

For more information, contact NACDS’ Sandra Guckian at 703-837-4195.

2021-05-07T11:54:47-04:00May 7, 2021|California|

Florida

The Board of Pharmacy published a notice to amend regulations under FAC 64B16-31 to update the incorporated pharmacist licensure and pharmacy intern and technician registration forms.

Also in Florida, the Department of Health published a notice of a workshop to adopt regulations under FAC 64J-4 to establish requirements for the Prescription Drug Donation Repository Program. The workshop is scheduled for May 14, 2021, via video and teleconference.

For more information, contact NACDS’ Leigh Knotts at 803-408-9774.

2021-05-07T11:54:36-04:00May 7, 2021|Florida|

Hawaii

HB 386, mandating the pharmaceutical industry fund a product stewardship program for the collection and destruction of unused drugs, failed to pass before adjournment of the legislature.

For more information, contact NACDS’ Sandra Guckian at 703-837-4195.

2021-05-07T11:54:24-04:00May 7, 2021|Hawaii|

Kentucky

MedImpact will hold a series of informational webinars for providers to share information on the transition to a single PBM, which will be effective July 1, 2021. The seminars will be held on May 14, June 15, and July 15, 2021. For more information on the seminars and other information about the transition, click here.

For more information, contact NACDS’ Jill McCormack at 717-525-8962.

2021-05-07T11:54:10-04:00May 7, 2021|Kentucky|

North Carolina

The Board of Pharmacy has issued guidance that allows for the pharmacist-manager to expand the pharmacist-technician ratio to 3:1 or 4:1 if in the judgment of the pharmacist-manager demonstrates that the pharmacy employs enough certified technicians to meet the ratio.

Also in North Carolina, the Board of Pharmacy has initiated rulemaking to expand the use of centralized processing for all pharmacies. The Board will hold a remote public hearing on July 20, 2021, at 10:00 am. Written comments will be accepted until July 20, 2021.

For more information, contact NACDS’ Leigh Knotts at 803-408-9774.

2021-05-07T11:53:57-04:00May 7, 2021|North Carolina|

Arkansas

Gov. Asa Hutchinson (R) signed into law SB 505/Act 651 legislation requiring prescribers to co-prescribe an opioid antagonist to patients under certain conditions: (1) dosage is equal to or above 50MME per day; (2) benzodiazepine has been prescribed or will be prescribed at the same time as the opioid; and (3) the patient has a history of drug abuse or a drug overdose.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2021-04-30T09:18:55-04:00April 30, 2021|Arkansas|

California

The COVID-19 Vaccine Administration Frequently Asked Questions (FAQs) page previously found on the Medi-Cal Provider website has been divided into separate FAQs for providers and beneficiaries. These documents are available on the COVID-19 Medi-Cal Response webpage under the FAQs section.  As a reminder, the Coronavirus (COVID-19) Uninsured Group FAQs are also available along with the providers and beneficiaries FAQs.

Also in California, the Department of Health Care Services launched its series of ongoing releases of enhancements, updates, and changes to improve and enhance its website navigation and user experience. A complete list of the enhancements, updates, and additional website changes can be viewed within the Medi-Cal Provider Website Release Change Log. Providers are also encouraged to subscribe to the free Medi-Cal Subscription Service (MCSS). The MCSS allows each subscriber to choose and tailor both the subject matters and types of communications they wish to receive from the Medi-Cal Program.

Lastly in California, the Board of Pharmacy recently distributed the following to licensees and stakeholders:

  • Updated draft versions of self-assessment forms for pharmacies and wholesalers are now posted in addition to currently adopted versions on the Board of Pharmacy website. The Board is in the process of approving the draft versions through formal rulemaking. Board regulations require pharmacies and wholesalers to complete adopted versions of self-assessment forms. However, completion of either adopted or draft versions is acceptable. The Board believes updated draft versions provide a more helpful assessment of pharmacies and wholesalers. The drafts include references to statutory and regulatory changes that occurred between 2012 and the revision date of each draft form. Self-assessments must be performed before July 1 of every odd-numbered year. Completed self-assessment forms must remain at the facility unless the Board requests submission of the form. To find the forms, go to pharmacy.ca.gov. Under the “Licensees” tab, click on Facility License Information/Renewal and scroll down to the link for Self-Assessment Forms.
  • The California State Board of Pharmacy extends its gratitude to all its licensees working to address the COVID-19 pandemic, including the most recent vaccination efforts underway in many pharmacies. As vaccine supplies continue to increase and vaccine eligibility expands, the Board would like to encourage pharmacies to plan appropriately when electing to provide COVID-19 vaccination services.  Such planning should include:
    • Ensuring sufficient staffing to maintain other pharmacy services while balancing vaccination services.
    • Ensuring sufficient space to provide vaccinations safely, and sufficient space and chairs for patients to remain seated during the recommended period of observation.
    • Ensuring appropriate staff is observing patients following administration of the vaccine.
  • Ensuring vaccination appointments can safely be accommodated with the staffing resources available.
  • In light of Governor Gavin Newsom’s declaration of emergency and the national declaration of emergency, and consistent with Business and Professions Code (BPC) section 4062, the California State Board of Pharmacy (Board) or the Board president through delegated authority has issued the following waivers.
    • Mass Vaccination Sites
      • Amended and Reissued:  April 21, 2021
      • Expiration: July 18, 2021
    • Supervision of Pharmacy Interns
      • Effective:  April 22, 2021
      • Expiration:  July 20, 2021

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2021-04-30T09:19:53-04:00April 30, 2021|California|

Colorado

On April 24, the Pharmacy Sunset legislation pharmacies support that expands our scope of practice unanimously passed the Senate and is now pending further action in the House where we will push to have it scheduled in committee as soon as possible.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2021-04-30T09:16:36-04:00April 30, 2021|Colorado|

Indiana

House Bill 1405 PBM reform legislation NACDS supported led by Meijer passed the General Assembly and was sent to Gov. Eric Holcomb (R). There were multiple provisions important to pharmacies including (1) prohibitions on quantity or refill limits, (2) weekly MAC list updates, (3) notification to all pharmacies on successful MAC appeals and adjustments, and (4) established a formal complaint process for addressing MAC appeals and contractual issues.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2021-04-30T09:15:36-04:00April 30, 2021|Indiana|
Go to Top